Hologic's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Hologic (HOLX)

Q2 2012 Earnings Call

April 30, 2012 8:15 am ET


Deborah R. Gordon - Vice President of Investor Relations

Robert A. Cascella - Chief Executive Officer, President and Director

Glenn P. Muir - Chief Financial Officer, Executive Vice President of Finance & Administration and Director

Carl W. Hull - Chairman, Chief Executive Officer and President


William R. Quirk - Piper Jaffray Companies, Research Division

Bill Bonello - RBC Capital Markets, LLC, Research Division

David R. Lewis - Morgan Stanley, Research Division

Doug Schenkel - Cowen and Company, LLC, Research Division

Isaac Ro - Goldman Sachs Group Inc., Research Division

Amit Bhalla - Citigroup Inc, Research Division

Quintin J. Lai - Robert W. Baird & Co. Incorporated, Research Division

Richard Newitter - Leerink Swann LLC, Research Division

Nandita Koshal - Barclays Capital, Research Division

Brian Weinstein - William Blair & Company L.L.C., Research Division

Sara Michelmore - Brean Murray, Carret & Co., LLC, Research Division

Peter Lawson - Mizuho Securities USA Inc., Research Division



Good day, everyone, and welcome to the Hologic to acquire Gen-Probe Conference Call. Today's conference is being recorded. At this time, it is my pleasure to turn the conference over to Deb Gordon, VP of Investor Relations, Hologic. Please go ahead.

Deborah R. Gordon

Thank you, Nicole, and good morning. My name is Deborah Gordon, Vice President of Investor Relations at Hologic, and let me start by thanking you for joining us on short notice for this morning's conference call. On this call, we will briefly discuss Hologic's second quarter fiscal 2012 and Gen-Probe's first quarter 2012 results. We will then spend a majority of our time discussing the very exciting news announced in a separate press release this morning about the combination of Hologic and Gen-Probe. Please note, the replay of this call will be archived on Hologic's and Gen-Probe's respective websites through Friday, May 18. In addition, please note that the press releases and the presentations we will be reviewing on today's call are available in the Investor Relations sections of each company's website.

If you liked this article you might like

These Stocks Are Ready to Reverse Course

Hologic Looks Good on the Charts

Five S&P 500 Boards Have No Women as Gender Balance Growth Stalls

Merck Up on Approval, Teva Sinks on Earnings and Asset Sales: Biotech Movers

Cramer: These Sectors Look Bullish (Part III)